Eurepa-V 0.5/0.2 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Repaglinide (0.5mg) + Voglibose (0.2mg)
Overview Eurepa-V 0.5/0.2 Tablet
DiabetaComb 0.5/0.2 tablets combine two medications to manage type 2 diabetes. This dual-action formulation helps regulate postprandial hyperglycemia (high blood sugar after meals). It's prescribed when diet and other similar treatments prove insufficient to control elevated blood glucose. DiabetaComb 0.5/0.2 should be ingested immediately following meals; dosage is determined by your physician. Discontinuation requires medical consultation; abrupt cessation can elevate blood sugar, risking severe complications including renal impairment and vision loss. Missed doses shouldn't be compensated between meals; take the next dose as usual with your next meal. Never double the dose. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Common, typically transient side effects include gas, diarrhea, abdominal discomfort, hypoglycemia (low blood sugar), and skin reactions. Persistent or severe side effects warrant medical attention. Regular blood glucose monitoring is essential. Prior to commencing treatment, inform your doctor of any kidney, liver, or urinary tract issues, diuretic use, or pregnancy/breastfeeding. Limit alcohol consumption, as it may heighten the risk of adverse effects.
Uses of Eurepa-V 0.5/0.2 Tablet
Managing type 2 diabetes
Major Benefits of Eurepa-V 0.5/0.2 Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Eurepa-V 0.5/0.2 Tablet with food.
Common Side effects of Eurepa-V 0.5/0.2 Tablet:
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Diarrhea
- Flatulence
- Headache
How to use Eurepa-V 0.5/0.2 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Eurepa-V 0.5/0.2 Tablet with a meal.
How Eurepa-V 0.5/0.2 Tablet works:
Each Eurepa-V 0.5/0.2 tablet contains a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Eurepa-V 0.5/0.2 Tablet and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Eurepa-V 0.5/0.2 Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Eurepa-V 0.5/0.2 Tablet while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with severe renal impairment should use Eurepa-V 0.5/0.2 Tablet cautiously, as dose modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Eurepa-V 0.5/0.2 Tablet. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Eurepa-V 0.5/0.2 Tablet :
Should you forget a Eurepa-V 0.5/0.2 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eurepa-V 0.5/0.2 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
3,018 People bought this recently